G Gitsch
Overview
Explore the profile of G Gitsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
586
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasanov M, Denschlag D, Seemann E, Gitsch G, Woll J, Klar M
Arch Gynecol Obstet
. 2017 Dec;
297(2):409-414.
PMID: 29222641
Objective: To compare operating time and blood loss in patients undergoing total laparoscopic hysterectomies (TLH) for benign conditions with either the Marseal™ IQ 5 mm (MS) or the Ligasure™ 5 ...
2.
Lambers K, Hasenburg A, Stickeler E, Gitsch G, Grosu A, Henne K, et al.
Eur J Gynaecol Oncol
. 2016 Apr;
37(1):48-52.
PMID: 27048109
Objective: The objective of this retrospective study was to analyze the experience with intraoperative radiation therapy (IORT) at the present institution and to evaluate its contribution to the management of...
3.
Klar M, Farthmann J, Bossart M, Stremmel C, Gitsch G, Passlick B, et al.
Gynecol Oncol
. 2012 May;
126(3):397-402.
PMID: 22613353
Objectives: The aim of this study was to assess the influence of video-assisted thoracic surgery (VATS) on our treatment decisions in FIGO III and IV ovarian cancer patients. Methods: Patients...
4.
Stemmler H, Digioia D, Freier W, Tessen H, Gitsch G, Jonat W, et al.
Br J Cancer
. 2011 Mar;
104(7):1071-8.
PMID: 21407218
Background: An increasing proportion of patients are exposed to anthracyclines and/or taxanes in the adjuvant or neoadjuvant setting. Re-exposure in the metastatic stage is limited by drug resistance, thus evaluation...
5.
Klar M, Meyer P, Hancke K, Brink I, Orlowska-Volk M, Gitsch G, et al.
Anticancer Res
. 2010 Oct;
30(9):3787-90.
PMID: 20944170
Background: In order to decrease surgery-related morbidity, we evaluated the reliability of the evaluation of lymph node metastasis in patients with uterine corpus cancer by positron-emission tomography (PET) with 2-[(18)F]fluoro-2-deoxy-D-glucose...
6.
Hancke K, Foeldi M, Zahradnik H, Gitsch G, Gilbert L, Denschlag D
Climacteric
. 2010 Jan;
13(3):271-7.
PMID: 20082601
Objective: To determine whether the prescribing practice of physicians with regard to estrogen replacement therapy (ERT) in symptomatic women with previous endometrial cancer is consistent with the available evidence. Methods:...
7.
Stumpf M, Hasenburg A, Riener M, Jutting U, Wang C, Shen Y, et al.
Br J Cancer
. 2009 Oct;
101(9):1513-21.
PMID: 19861998
Background: The aim of this study was to investigate the prognostic effect of tumour-infiltrating lymphocytes (TILs) in serous stage III ovarian carcinoma to determine TIL clonality and to correlate this...
8.
Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D
Ann Surg Oncol
. 2009 Mar;
16(5):1136-42.
PMID: 19259742
Background: The sentinel lymph node (SLN) procedure could be omitted in cases of accurate prediction of very high or very low probability of SLN metastasis in early breast cancer patients....
9.
Lassmann S, Shen Y, Jutting U, Whiele P, Walch A, Gitsch G, et al.
Verh Dtsch Ges Pathol
. 2008 Mar;
91:225-32.
PMID: 18314619
Aim: Overexpression of Aurora-A/STK15 kinase (hereafter AUKRA) is seen in a variety of epithelial cancers, such as gastrointestinal and gynaecological carcinomas. Its role as prognostic and/or predictive marker for adjuvant...
10.
Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E, et al.
Breast Cancer Res Treat
. 2008 Jan;
112(3):523-31.
PMID: 18172758
Objective: To assess whether the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram for prediction of NSLN metastasis is useful in a German breast cancer population and whether the characteristics of...